Role of the ret proto-oncogene in the development of the enteric nervous system

ret原癌基因在肠神经系统发育中的作用

基本信息

  • 批准号:
    06454192
  • 负责人:
  • 金额:
    $ 4.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

Immunohistochemical analysis with the anti-Ret antibody was performed to investigate the expression of the c-ret proto-oncogene product (c-Ret protein) in embryonic, and adult rat tissues. During embryogenesis, it was expressed at high levels in the enteric neuroblasts and the sympathetic ganglia. c-Ret positive cells appeared in the mesenchyme around the rofegut and the dorsal aorta at day 11.5 and formed the myeteric plexus of the whole embryonic gut and the sympathetic truck at later stages, respectively. In the enteric nervous system, c-Ret positive cells began to contact each other to form the myenteric ganglia and were arranged between the muscle layrs. After birth, these neurons continued to express the c-Ret protein at variable levels. These results suggested that the c-Ret protein might be involved in the development of the enteric and sympathetic nervous system.We introduced several mutations of the ret proto-oncogene found in the Hirchsprung's disease.ret cDNA with each mutation was transfected into NIH 3T3 cells, cell lines expressing the mutant Ret proteins were established. The Ret proteins were usually expressed as a mature glycosylated form of 170 kDa protein present on the cell surface and an immature glycosylated form of the 150 kDa Ret protein in the endoplasmic reticulum. Western blot analysis revealed that very little of the 170 kDa Ret protein was expressed in transfectants while expression of the 150 kDa Ret protein was not affected. This result suggested that the Hirschsprung mutations impair the transport of the Ret protein to the plasma membrane.
用抗Ret抗体进行免疫组织化学分析,以研究胚胎和成年大鼠组织中c-Ret原癌基因产物(c-Ret蛋白)的表达。在胚胎发育过程中,它在肠神经母细胞和交感神经节中高水平表达。c-Ret阳性细胞于11.5d出现在小肠和背主动脉周围的间充质中,后期分别形成整个胚胎肠的肠系膜丛和交感神经干。在肠神经系统中,c-Ret阳性细胞开始相互接触,形成肌间神经节,并排列在肌层之间。出生后,这些神经元继续以不同的水平表达c-Ret蛋白。本研究将在先天性巨结肠病中发现的ret原癌基因的几个突变点导入NIH 3 T3细胞,建立了表达突变Ret蛋白的细胞系。Ret蛋白通常表达为存在于细胞表面上的170 kDa蛋白的成熟糖基化形式和存在于内质网中的150 kDa Ret蛋白的未成熟糖基化形式。Western印迹分析表明,非常少的170 kDa的Ret蛋白表达的转染子,而表达的150 kDa的Ret蛋白不受影响。该结果表明,先天性巨结肠突变损害了Ret蛋白向质膜的转运。

项目成果

期刊论文数量(48)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yoshio.Watanabe: "Expression of ret proto-oncogene products in the hypoganglionic segment of the small intestine of congenital aganglionosis rats." J.Pediatr.Surg.30. 641-645 (1995)
Yoshio.Watanabe:“先天性无神经节病大鼠小肠下节段中 ret 原癌基因产物的表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Wada, M., Asai, N., Tsuzuki, T., Maruyama, S., Ohiwa, M., Imai, T., Funahashi, H., Takagi, H.and Takahashi, M.: "Detection of Ret homodimers in MEN 2A-associated pheochromocytomas." Biochem.Biophys.Res.Commun.218. 606-609 (1996)
Wada, M.、Asai, N.、Tsuzuki, T.、Maruyama, S.、Ohiwa, M.、Imai, T.、Funahashi, H.、Takagi, H. 和 Takahashi, M.:“Ret 同二聚体的检测
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toshihide Iwashita: "Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN 2A or MEN 2B mutation." Oncogene. 12. 481-487 (1996)
Toshihide Iwashita:“鉴定对于 MEN 2A 或 MEN 2B 突变的 ret 原癌基因的活性转化至关重要的酪氨酸残基。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toyonori.Tsuzuki: "Spatial and temporal expression of the ret proto-oncogene product in embryonic,infant and adult rat tissues." Oncogene. 10. 191-198 (1995)
Toyonori.Tsuzuki:“ret 原癌基因产物在胚胎、婴儿和成年大鼠组织中的空间和时间表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toshihide.Iwashita: "Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation." Oncogene. 12. 481-487 (1996)
Toshihide.Iwashita:“鉴定对于具有 MEN2A 或 MEN2B 突变的 ret 原癌基因的活性转化至关重要的酪氨酸残基。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKAHASHI Masahide其他文献

TAKAHASHI Masahide的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKAHASHI Masahide', 18)}}的其他基金

Mechanism of chemoresistance by HDAC1-associating protein and development of molecular targeted therapy
HDAC1相关蛋白的化疗耐药机制及分子靶向治疗的进展
  • 批准号:
    24650618
  • 财政年份:
    2012
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular mechanisms of postnatal angiogenesis and neurogenesis
出生后血管生成和神经发生的分子机制
  • 批准号:
    23249020
  • 财政年份:
    2011
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Enhanced photoresponse in organically-modified oxo alternating copolymers
有机改性的含氧交替共聚物增强光响应
  • 批准号:
    22360276
  • 财政年份:
    2010
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Organic-inorganic hybrid films with photo and stimuli responsive micro structures
具有光和刺激响应微结构的有机-无机杂化薄膜
  • 批准号:
    22655071
  • 财政年份:
    2010
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Physiological functions of the Akt substrate Girdin and its family proteins and their roles in pathogenesis
Akt 底物 Girdin 及其家族蛋白的生理功能及其在发病机制中的作用
  • 批准号:
    19209013
  • 财政年份:
    2007
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Regulation of cell proliferation by receptor tyrosine kinase
受体酪氨酸激酶对细胞增殖的调节
  • 批准号:
    17014039
  • 财政年份:
    2005
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
In vivo role of the GDNF/RET signaling pathway in morphogenesis and pathogenesis
GDNF/RET 信号通路在形态发生和发病机制中的体内作用
  • 批准号:
    15209014
  • 财政年份:
    2003
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of low-melting glasses containing organic molecules for photoinduced refractive index change
开发含有有机分子的低熔点玻璃以实现光致折射率变化
  • 批准号:
    12555249
  • 财政年份:
    2000
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Medicine of Neurodegenerative Disease and Malignant Tumor
神经退行性疾病和恶性肿瘤的分子医学
  • 批准号:
    10CE2006
  • 财政年份:
    1998
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for COE Research
Analysis of molecular mechanisms of cancer metastasis using transgenic mice
利用转基因小鼠分析癌症转移的分子机制
  • 批准号:
    09470062
  • 财政年份:
    1997
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Molecular mechanism of membrane association of Bruton's Tyrosine Kinase
布鲁顿酪氨酸激酶膜缔合的分子机制
  • 批准号:
    10604872
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
Elucidating anti-angiogenic tyrosine kinase inhibitor-induced vascular dysfunction
阐明抗血管生成酪氨酸激酶抑制剂诱导的血管功能障碍
  • 批准号:
    10570393
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
Receptor tyrosine kinase signaling in astrocyte migration and angiogenesis
星形胶质细胞迁移和血管生成中的受体酪氨酸激酶信号传导
  • 批准号:
    10734124
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
Tuning tyrosine kinase signalling to improve haematopoietic stem cell expansion and bone marrow transplantation
调节酪氨酸激酶信号传导以改善造血干细胞扩增和骨髓移植
  • 批准号:
    2889841
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Studentship
The multifaceted role of c-Src tyrosine kinase in breast cancer progression.
c-Src 酪氨酸激酶在乳腺癌进展中的多方面作用。
  • 批准号:
    468470
  • 财政年份:
    2022
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Operating Grants
Enhancing Anti-Cancer Immunotherapy by Disruption of the non-Receptor Tyrosine Kinase Fes
通过破坏非受体酪氨酸激酶 Fes 增强抗癌免疫治疗
  • 批准号:
    476093
  • 财政年份:
    2022
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Studentship Programs
Investigating Resistance Mechanisms to Non-covalent Bruton's Tyrosine Kinase Inhibitors and Therapeutic Approaches to Overcome Resistance for Patients with B-Cell Malignancies
研究非共价布鲁顿酪氨酸激酶抑制剂的耐药机制以及克服 B 细胞恶性肿瘤患者耐药性的治疗方法
  • 批准号:
    10537252
  • 财政年份:
    2022
  • 资助金额:
    $ 4.22万
  • 项目类别:
Design and Synthesis of Novel Action Inhibitors for Bruton's Tyrosine Kinase (BTK)
布鲁顿酪氨酸激酶 (BTK) 新型作用抑制剂的设计与合成
  • 批准号:
    2751540
  • 财政年份:
    2022
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Studentship
Receptor Tyrosine Kinase Transactivation in Neuronal Signalling, Stress, and Survival
受体酪氨酸激酶反式激活对神经元信号传导、应激和生存的影响
  • 批准号:
    RGPIN-2019-04177
  • 财政年份:
    2022
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Discovery Grants Program - Individual
Repurposing Bruton's tyrosine kinase (BTK) inhibitors to reverse immunosuppression in high-grade serous ovarian cancer (HGSC)
重新利用布鲁顿酪氨酸激酶 (BTK) 抑制剂来逆转高级别浆液性卵巢癌 (HGSC) 的免疫抑制
  • 批准号:
    10661823
  • 财政年份:
    2022
  • 资助金额:
    $ 4.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了